What's In Store For Crocs Q3 Earnings? Analyst Eyes North America Trends
Portfolio Pulse from Nabaparna Bhattacharya
BofA Securities analyst Christopher Nardone reiterated a Buy rating on Crocs, Inc (NASDAQ:CROX) with a price target of $179, ahead of its Q3 earnings report. The analyst projects EPS of $3.17, slightly above guidance and consensus estimates, driven by strong international sales. Attention is on North America trends and the impact of a shift to direct-to-consumer sales. CROX stock has gained over 62% in the past year.
October 18, 2024 | 5:58 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Investors can gain exposure to Crocs through the Advisors Series Trust VegTech Plant-based Innovation & Climate ETF (NYSE:EATV).
EATV provides exposure to Crocs, but the direct impact of Crocs' earnings on EATV is limited. The ETF's performance is influenced by a broader range of factors beyond Crocs alone.
CONFIDENCE 80
IMPORTANCE 30
RELEVANCE 20
NEUTRAL IMPACT
Investors can gain exposure to Crocs through the Advisor Managed Portfolios Miller Value Partners Appreciation ETF (NYSE:MVPA).
MVPA provides exposure to Crocs, but the direct impact of Crocs' earnings on MVPA is limited. The ETF's performance is influenced by a broader range of factors beyond Crocs alone.
CONFIDENCE 80
IMPORTANCE 30
RELEVANCE 20
POSITIVE IMPACT
BofA Securities analyst Christopher Nardone reiterated a Buy rating on Crocs, Inc with a price target of $179. The analyst projects Q3 EPS of $3.17, slightly above guidance and consensus estimates, driven by strong international sales. Attention is on North America trends and the impact of a shift to direct-to-consumer sales.
The reiteration of a Buy rating and a price target of $179 by a reputable analyst is a positive signal for investors. The projected EPS exceeding guidance and consensus estimates suggests strong performance, particularly in international sales. The focus on North America trends and DTC sales impact is crucial, as stability or growth in this area could alleviate investor concerns. The stock's significant gain over the past year further supports a positive outlook.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100